BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...

Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...

First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...

In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...

It has been a pivotal year in the area of Alzheimer’s disease (AD). In May, the...

Scientists from Trinity College Dublin have discovered that electrical stimulation modulates human macrophage function to favour...

A study presented at the recent European Emergency Medicine (EUSEM) Congress found liquid or powder nasal...

Scientists have discovered how cells in the small intestine of coeliac patients communicate with one another...

Patients with pancreatic cancer continue to face a poor prognosis, with just 13 per cent of...

Approximately 7 per cent of individuals worldwide suffer from functional dyspepsia (FD), according to the results...

Results from the international phase 3 Amplitude trial, presented at the 2025 American Society of Clinical...

Last month, the European Hematology Association (EHA) and the European Myeloma Network (EMN) issued new guidelines...